Exact Mass: 411.23857680000003

Exact Mass Matches: 411.23857680000003

Found 301 metabolites which its exact mass value is equals to given mass value 411.23857680000003, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Acetophenazine

1-(10-{3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl}-10H-phenothiazin-2-yl)ethan-1-one

C23H29N3O2S (411.19803740000003)

Acetophenazine is only found in individuals that have used or taken this drug.It is an antipsychotic drug of moderate-potency. It is used in the treatment of disorganized and psychotic thinking. It is also used to help treat false perceptions (e.g. hallucinations or delusions).Acetophenazine blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis. N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

Lasiocarpine

(1S,7aR)-7-({[2,3-dihydroxy-2-(1-methoxyethyl)-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1H-pyrrolizin-1-yl (2Z)-2-methylbut-2-enoate (non-preferred name)

C21H33NO7 (411.22569080000005)

CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2259 Origin: Plant; SubCategory_DNP: Alkaloids derived from ornithine, Pyrrolizidine alkaloids

Etorphine

6,14-Ethenomorphinan-7-methanol, 4,5-epoxy-3-hydroxy-6-methoxy-alpha,17-dimethyl-alpha-propyl-, (5alpha,7alpha(R))-

C25H33NO4 (411.2409458000001)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics Same as: D07937

LysoPC(10:0/0:0)

(2-{[(2R)-3-(decanoyloxy)-2-hydroxypropyl phosphono]oxy}ethyl)trimethylazanium

C18H38NO7P (411.23857680000003)

LysoPC(10:0/0:0) is a lysophosphatidylcholine, which is a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2 as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. There is also a phospholipase A1, which is able to cleave the sn-1 ester bond. Lysophosphatidylcholine has pro-inflammatory properties in vitro and it is known to be a pathological component of oxidized lipoproteins (LDL) in plasma and of atherosclerotic lesions. Recently, it has been found to have some functions in cell signalling, and specific receptors (coupled to G proteins) have been identified. It activates the specific phospholipase C that releases diacylglycerols and inositol triphosphate with resultant increases in intracellular Ca2+ and activation of protein kinase C. It also activates the mitogen-activated protein kinase in certain cell types. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPC(10:0/0:0), in particular, consists of one chain of capric acid at the C-1 position. 1-Decanoyllysolecithin is a glycerophosphocholine. Glycerophosphocholines are a class of glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the SN-1 and SN-2 positions. fatty acids containing 16, 18 and 20 carbons are the most common. (LipidMAPS) [HMDB]

Carphenazine

1-(10-{2-[4-(2-hydroxyethyl)piperazin-1-yl]ethyl}-10H-phenothiazin-2-yl)propan-1-one

C23H29N3O2S (411.19803740000003)

Carphenazine is only found in individuals that have used or taken this drug. It is an antipsychotic drug, used in hospitalized patients in the management of chronic schizophrenic psychoses.A yellow, powdered, phenothiazine antipsychotic agent used in the treatment of acute or chronic schizophrenia. The term "phenothiazines" is used to describe the largest of the five main classes of neuroleptic antipsychotic drugs. These drugs have antipsychotic and, often, antiemetic properties, although they may also cause severe side effects such as akathisia, tardive dyskinesia and extrapyramidal symptoms. Carphenazine blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis.

Fesoterodine

2-[(1R)-3-[bis(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl 2-methylpropanoate

C26H37NO3 (411.27732920000005)

Fesoterodine is only found in individuals that have used or taken this drug. It is an antimuscarinic prodrug used for treating overactive bladder syndrome.Fesoterodine, once converted to its active metabolite, 5-hydroxymethyltolterodine, acts as a competitive antagonists at muscarinic receptors. This results in the inhibition of bladder contraction, decrease in detrusor pressure, and an incomplete emptying of the bladder. G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BD - Drugs for urinary frequency and incontinence C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents

N-Linoleoyl Methionine

2-[(1-Hydroxyoctadeca-9,12-dien-1-ylidene)amino]-4-(methylsulphanyl)butanoic acid

C23H41NO3S (411.28069960000005)

N-linoleoyl methionine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Linoleic acid amide of Methionine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Linoleoyl Methionine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Linoleoyl Methionine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

Etorphine

19-(2-hydroxypentan-2-yl)-15-methoxy-3-methyl-13-oxa-3-azahexacyclo[13.2.2.1^{2,8}.0^{1,6}.0^{6,14}.0^{7,12}]icosa-7,9,11,16-tetraen-11-ol

C25H33NO4 (411.2409458000001)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

1,2-Dihexanoyl-sn-glycero-3-phosphoethanolamine

(2-aminoethoxy)[2,3-bis(hexanoyloxy)propoxy]phosphinic acid

C17H34NO8P (411.2021934)

1-(2-(4-(3-Phenyl-2H-1-benzopyran-2-yl)phenoxy)ethyl)piperidine

C28H29NO2 (411.2198174)

Piroxantrone

10-[(3-aminopropyl)imino]-6,8-dihydroxy-14-{2-[(2-hydroxyethyl)amino]ethyl}-14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1,4,6,8,11,13(16)-hexaen-3-one

C21H25N5O4 (411.190645)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents

Sacubitril

3-[(1-{[1,1-biphenyl]-4-yl}-5-ethoxy-4-methyl-5-oxopentan-2-yl)-C-hydroxycarbonimidoyl]propanoate

C24H29NO5 (411.20456240000004)

Teloxantrone

6,8-dihydroxy-14-{2-[(2-hydroxyethyl)amino]ethyl}-10-{[2-(methylamino)ethyl]imino}-14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1,4,6,8,11,13(16)-hexaen-3-one

C21H25N5O4 (411.190645)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

N-Arachidonoyl taurine

N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-taurine

C22H37NO4S (411.24431620000007)

Q63392953

C23H29N3O2S (411.19803740000003)

SCHEMBL5850924

C26H37NO3 (411.27732920000005)

13a-hydroxysepticine

C24H29NO5 (411.20456240000004)

Latrunculin M

C21H33NO5S (411.2079328000001)

dysolenticin J

C26H37NO3 (411.27732920000005)

A natural product found in Dysoxylum lenticellatum.

[6]-Zingerine

C22H29N5O3 (411.2270284)

isariotin L

C21H33NO7 (411.22569080000005)

didymellamide C

C24H29NO5 (411.20456240000004)

9-[2-amino-3-(4'-O-methyl-alpha-ribopyranosyloxy)phenyl]nonanoic acid

9-[2-amino-3-(4"-O-methyl-alpha-ribopyranosyloxy)phenyl]nonanoic acid

C21H33NO7 (411.22569080000005)

Brachystamide C|brachystamide-C|N-isobutyl-15-(3,4-methylenedioxyphenyl)-2E,4E,13E-pentadecatrienamide

C26H37NO3 (411.27732920000005)

Sch 382583

C21H37N3O5 (411.27330720000003)

O-Acetyljacoline

C20H29NO8 (411.1893074)

brevicompanine D

C24H33N3O3 (411.2521788)

Lys Lys His

C18H33N7O4 (411.2593898)

Gln Lys His

C17H29N7O5 (411.22300640000003)

Lys His Gln

C17H29N7O5 (411.22300640000003)

lysylhistidyllysine

C18H33N7O4 (411.2593898)

His Glu Leu

C18H29N5O6 (411.2117734)

Phe Phe Val

C23H29N3O4 (411.21579540000005)

Leu Glu His

C18H29N5O6 (411.2117734)

His Lys Gln

C17H29N7O5 (411.22300640000003)

Lys Gln His

C17H29N7O5 (411.22300640000003)

Glu Leu His

C18H29N5O6 (411.2117734)

histidyllysyllysine

C18H33N7O4 (411.2593898)

Glu His Leu

C18H29N5O6 (411.2117734)

histidylglutaminyllysine

C17H29N7O5 (411.22300640000003)

His Leu Glu

C18H29N5O6 (411.2117734)

DTXSID20875454

C23H29N3O4 (411.21579540000005)

Leu His Glu

C18H29N5O6 (411.2117734)

Val Phe Phe

C23H29N3O4 (411.21579540000005)

Lasiocarpine

2-BUTENOIC ACID, 2-METHYL-, 7-((2,3-DIHYDROXY-2-(1-METHOXYETHYL)-3-METHYL-1-OXOBUTOXY)METHYL)-2,3,5,7A-TETRAHYDRO-1H-PYRROLIZIN-1-YL ESTER, (1S-(1.ALPHA.(Z),7(S*(R*)),7A.ALPHA.))-

C21H33NO7 (411.22569080000005)

Lasiocarpine appears as colorless plates or beige crystalline solid. (NTP, 1992) Lasiocarpine is a natural product found in Heliotropium arbainense, Heliotropium suaveolens, and other organisms with data available. See also: Comfrey Leaf (part of); Comfrey Root (part of).

ACETOPHENAZINE

C23H29N3O2S (411.19803740000003)

N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

1-Decanoyl-2-hydroxy-sn-glycero-3-phosphocholine

C18H38NO7P (411.23857680000003)

(2E,4E,14E)-15-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)pentadeca-2,4,14-trienamide

NCGC00385245-01!(2E,4E,14E)-15-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)pentadeca-2,4,14-trienamide

C26H37NO3 (411.27732920000005)

C23H29N3O4_1H,5H-Imidazo[1,2:1,2]pyrido[2,3-b]indole-2,5(3H)-dione, 7a-(1,1-dimethyl-2-propen-1-yl)-7a,12-dihydro-6,12-dimethoxy-3-(1-methylethyl)

NCGC00380951-01_C23H29N3O4_1H,5H-Imidazo[1,2:1,2]pyrido[2,3-b]indole-2,5(3H)-dione, 7a-(1,1-dimethyl-2-propen-1-yl)-7a,12-dihydro-6,12-dimethoxy-3-(1-methylethyl)-

C23H29N3O4 (411.21579540000005)

(2E,4E,14E)-15-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)pentadeca-2,4,14-trienamide [IIN-based on: CCMSLIB00000848860]

NCGC00385245-01!(2E,4E,14E)-15-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)pentadeca-2,4,14-trienamide [IIN-based on: CCMSLIB00000848860]

C26H37NO3 (411.27732920000005)

(2E,4E,14E)-15-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)pentadeca-2,4,14-trienamide [IIN-based: Match]

NCGC00385245-01!(2E,4E,14E)-15-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)pentadeca-2,4,14-trienamide [IIN-based: Match]

C26H37NO3 (411.27732920000005)

1-decanoyl-sn-glycero-3-phosphocholine

1-Decanoyl-2-hydroxy-sn-glycero-3-phosphocholine

C18H38NO7P (411.23857680000003)

A 1-O-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as capryl (decanoyl).

Ala Gly His Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C17H29N7O5 (411.22300640000003)

Ala Gly Lys His

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2-aminopropanamido]acetamido}hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H29N7O5 (411.22300640000003)

Ala His Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}hexanoic acid

C17H29N7O5 (411.22300640000003)

Ala His Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]acetic acid

C17H29N7O5 (411.22300640000003)

Ala Lys Gly His

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C17H29N7O5 (411.22300640000003)

Ala Lys His Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C17H29N7O5 (411.22300640000003)

Ala Lys Pro Pro

(2S)-1-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C19H33N5O5 (411.24815680000006)

Ala Pro Lys Pro

(2S)-1-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}hexanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O5 (411.24815680000006)

Ala Pro Pro Lys

(2S)-6-amino-2-{[(2S)-1-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}hexanoic acid

C19H33N5O5 (411.24815680000006)

Ala Pro Pro Gln

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C18H29N5O6 (411.2117734)

Ala Pro Gln Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O6 (411.2117734)

Ala Gln Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C18H29N5O6 (411.2117734)

Gly Ala His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C17H29N7O5 (411.22300640000003)

Gly Ala Lys His

(2S)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)propanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H29N7O5 (411.22300640000003)

Gly His Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]propanamido]hexanoic acid

C17H29N7O5 (411.22300640000003)

Gly His Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]hexanamido]propanoic acid

C17H29N7O5 (411.22300640000003)

Gly Lys Ala His

(2S)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H29N7O5 (411.22300640000003)

Gly Lys His Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C17H29N7O5 (411.22300640000003)

His Ala Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]acetamido}hexanoic acid

C17H29N7O5 (411.22300640000003)

His Ala Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]hexanamido]acetic acid

C17H29N7O5 (411.22300640000003)

His Gly Ala Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}propanamido]hexanoic acid

C17H29N7O5 (411.22300640000003)

His Gly Lys Ala

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}hexanamido]propanoic acid

C17H29N7O5 (411.22300640000003)

His Lys Ala Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]propanamido]acetic acid

C17H29N7O5 (411.22300640000003)

His Lys Gly Ala

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]acetamido}propanoic acid

C17H29N7O5 (411.22300640000003)

Lys Ala Gly His

(2S)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C17H29N7O5 (411.22300640000003)

Lys Ala His Gly

2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C17H29N7O5 (411.22300640000003)

Lys Ala Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C19H33N5O5 (411.24815680000006)

Lys Gly Ala His

(2S)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H29N7O5 (411.22300640000003)

Lys Gly His Ala

(2S)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C17H29N7O5 (411.22300640000003)

Lys His Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]acetic acid

C17H29N7O5 (411.22300640000003)

Lys His Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}propanoic acid

C17H29N7O5 (411.22300640000003)

Lys Pro Ala Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}propanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O5 (411.24815680000006)

His Lys Lys

C18H33N7O4 (411.2593898)

Lys Pro Pro Ala

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanoic acid

C19H33N5O5 (411.24815680000006)

Gln His Lys

C17H29N7O5 (411.22300640000003)

Pro Ala Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O5 (411.24815680000006)

Pro Ala Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C19H33N5O5 (411.24815680000006)

Pro Ala Pro Gln

(2S)-4-carbamoyl-2-{[(2S)-1-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanoyl]pyrrolidin-2-yl]formamido}butanoic acid

C18H29N5O6 (411.2117734)

Pro Ala Gln Pro

(2S)-1-[(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O6 (411.2117734)

Pro Lys Ala Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]propanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O5 (411.24815680000006)

Pro Lys Pro Ala

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C19H33N5O5 (411.24815680000006)

Pro Pro Ala Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanamido]hexanoic acid

C19H33N5O5 (411.24815680000006)

Pro Pro Ala Gln

(2S)-4-carbamoyl-2-[(2S)-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanamido]butanoic acid

C18H29N5O6 (411.2117734)

Pro Pro Lys Ala

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}hexanamido]propanoic acid

C19H33N5O5 (411.24815680000006)

Pro Pro Gln Ala

(2S)-2-[(2S)-4-carbamoyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanamido]propanoic acid

C18H29N5O6 (411.2117734)

Pro Gln Ala Pro

(2S)-1-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O6 (411.2117734)

Pro Gln Pro Ala

(2S)-2-{[(2S)-1-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C18H29N5O6 (411.2117734)

Lys His Lys

C18H33N7O4 (411.2593898)

Gln Ala Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C18H29N5O6 (411.2117734)

Phe Val Phe

C23H29N3O4 (411.21579540000005)

Gln Pro Ala Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}propanoyl]pyrrolidine-2-carboxylic acid

C18H29N5O6 (411.2117734)

Gln Pro Pro Ala

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanoic acid

C18H29N5O6 (411.2117734)

His Gln Lys

C17H29N7O5 (411.22300640000003)

Platelet-activating factor

3,5,9-Trioxa-4-phosphaheptadecan-1-aminium, 7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (R)-

C18H38NO7P (411.23857680000003)

1-Decanoyllysolecithin

Decanoin, 1-mono-, 3-(dihydrogen phosphate), monoester with choline hydroxide, inner salt, L-

C18H38NO7P (411.23857680000003)

Decanoyllysophosphatidylcholine

3,5,9-Trioxa-4-phosphanonadecan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide

C18H38NO7P (411.23857680000003)

PC(0:0/10:0)[U]

3,5,8-Trioxa-4-phosphaoctadecan-1-aminium, 4-hydroxy-7-(hydroxymethyl)-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide

C18H38NO7P (411.23857680000003)

PE(6:0/6:0)

Hexanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester, (R)-

C17H34NO8P (411.2021934)

Dihexanoyl-alpha-ph

Hexanoin, 1,2-di-, 3-(dihydrogen phosphate), 2-aminoethyl ester

C17H34NO8P (411.2021934)

Piriprost

1,4(R),5(R),6-tetrahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-1-octenyl]-1-phenyl-cyclopenta[b]pyrrole-2-pentanoic acid

C25H33NO4 (411.2409458000001)

PE(13:0/0:0)

1-tridecanoyl-sn-glycero-3-phosphoethanolamine

C18H38NO7P (411.23857680000003)

Carphenazine

1-(10-{2-[4-(2-hydroxyethyl)piperazin-1-yl]ethyl}-10H-phenothiazin-2-yl)propan-1-one

C23H29N3O2S (411.19803740000003)

Fesoterodine

2-[(1R)-3-[bis(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl 2-methylpropanoate

C26H37NO3 (411.27732920000005)

G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BD - Drugs for urinary frequency and incontinence C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents

NAT 20:4

N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-taurine

C22H37NO4S (411.24431620000007)

NA 26:8;O

(5E,7E)-8-[(3aS,4R,5R,7aR)-4-[(1Z,3E)-5-oxo-5-(isobutylamino)-penta-1,3-dienyl]-2,3,3a,4,5,7a-hexahydro-1H-inden-5-yl]octa-5,7-dienoic acid

C26H37NO3 (411.27732920000005)

PC O-10:0

1-octyl-2-acetyl-sn-glycero-3-phosphocholine

C18H38NO7P (411.23857680000003)

LPC 10:0

1-Decanoyl-sn-glycerol-3-phosphorylcholine

C18H38NO7P (411.23857680000003)

PE 12:0

Hexanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester, (R)-

C17H34NO8P (411.2021934)

LPE 13:0

1-tridecanoyl-sn-glycero-3-phosphoethanolamine

C18H38NO7P (411.23857680000003)

Sphingofungin G

C22H37NO6 (411.26207420000003)

3-N-BOC-AMINO-1-[2-AMINO-1-(4-BENZYLOXY-PHENYL)-ETHYL]-PYRROLIDINE

C24H33N3O3 (411.2521788)

4-(Dicyanomethylene)-2-methyl-6-(1,1,7,7-tetramethyljulolidyl-9-enyl)-4H-pyran

C27H29N3O (411.2310504)

sacubitril

C24H29NO5 (411.20456240000004)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent

JTC-801 free base

N-(4-amino-2-methylquinolin-6-yl)-2-[(4-ethylphenoxy)methyl]benzamide

C26H25N3O2 (411.194667)

Hexadecyl trimethyl ammonium iodide

C19H42IN (411.2361842)

FMOC-L-BETA-HOMOTHREONINE(OTBU)

C24H29NO5 (411.20456240000004)

1-[12-(4-ethylphenyl)dodecoxy]-2-nitrobenzene

C26H37NO3 (411.27732920000005)

3-Amino-4-chlorobenzoic acid 2-dodecyloxy-1-methyl-2-oxoethyl ester

C22H34ClNO4 (411.2176234000001)

Fesoterodine maleate

C26H37NO3 (411.27732920000005)

2-(3-(1-Benzylpiperidin-4-yl)-2-oxopropyl)-4,5-dimethoxybenzoic Acid

C24H29NO5 (411.20456240000004)

1-(2-ethylhexyl)-1,2-dihydro-6-hydroxy-4-methyl-5-[(2-nitrophenyl)azo]-2-oxonicotinonitrile

C21H25N5O4 (411.190645)

Balicatib

C23H33N5O2 (411.26341180000003)

C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor C471 - Enzyme Inhibitor

Dobupride

C20H30ClN3O4 (411.19247300000006)

Fmoc-N-Me-Thr(tBu)-OH

C24H29NO5 (411.20456240000004)

1,3,3-Trimethylindolino-6-(1-piperidinyl)spironaphthoxazine

C27H29N3O (411.2310504)

(2R,4S)-ethyl 5-([1,1-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoate

C25H33NO4 (411.2409458000001)

Phenol,2-[4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl]-5-Methoxy

C26H25N3O2 (411.194667)

2R,4S-Sacubitril

C24H29NO5 (411.20456240000004)

MORPHOLINE

C29H33NO (411.25620080000004)

(R)-3-[1-(4-Fluoro-benzyl)-1H-benzoiMidazol-2-yloxy]-pyrrolidine-1-carboxylic acid tert-butyl ester

C23H26FN3O3 (411.1958098)

(2R,4S)-4-([1,1-Biphenyl]-4-ylmethyl)-4-(4-ethoxy-4-oxobutanamido)-2-methylbutanoic acid

C24H29NO5 (411.20456240000004)

(2R,3S)-O,O-DIACETYL-3-DIBENZYLAMINO-5-METHYLHEXANE-1,2-DIOL

C25H33NO4 (411.2409458000001)

AHU-377(Sacubitril)

C24H29NO5 (411.20456240000004)

rac N,N-Didesmethyl-O-desmethyl Venlafaxine Glucuronide

C20H29NO8 (411.1893074)

Difeterol hydrochloride

C25H30ClNO2 (411.196495)

1-O-Decylpropanediyl-3-phosphorylcholine

C18H38NO7P (411.23857680000003)

(4Z)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline

C29H35N2+ (411.280009)

1-[10-[3-[4-(2-Hydroxyethyl)piperazin-1-yl]propyl]phenothiazin-3-yl]ethanone

C23H29N3O2S (411.19803740000003)

(2R,3R,4S,7S)-3-[(3R,4R)-3,4-dihydroxypentanoyl]oxy-7-(3-hydroxyphenyl)-7-methoxy-2,4-dimethylheptanoate

C21H31O8- (411.2018826)

D009676 - Noxae > D011042 - Poisons > D008235 - Lyngbya Toxins D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins

N-Linoleoyl Methionine

C23H41NO3S (411.28069960000005)

(2S)-6-amino-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoic acid

C18H33N7O4 (411.2593898)

2-azaniumylethyl (2R)-2,3-bis(hexanoyloxy)propyl phosphate

C17H34NO8P (411.2021934)

2,11-Dimethoxy-9-(2-methylbut-3-en-2-yl)-14-propan-2-yl-2,13,16-triazatetracyclo[7.7.0.01,13.03,8]hexadeca-3,5,7,10-tetraene-12,15-dione

C23H29N3O4 (411.21579540000005)

(3R)-3-(2-fluoro-5-methylphenyl)-7-phenyl-2-(phenylmethyl)-3a,6,7,7a-tetrahydro-3H-isoindol-1-one

C28H26FNO (411.1998318)

1-Phenyl-4-[[1-(phenylmethyl)-5-tetrazolyl]-(3-pyridinyl)methyl]piperazine

C24H25N7 (411.217133)

2-[4-[(6-Ethoxy-2-quinolinyl)methyl]-1-(3-thiophenylmethyl)-2-piperazinyl]ethanol

C23H29N3O2S (411.19803740000003)

N,N-(6-((4-(hydroxy(phenyl)methyl)phenyl)amino)-6-oxohexane-1,5-diyl)diacetamide

C23H29N3O4 (411.21579540000005)

[2-(2-Methoxyethyl)-1-piperidinyl]-[5-[[4-(1,2,4-triazol-1-yl)phenoxy]methyl]-3-isoxazolyl]methanone

C21H25N5O4 (411.190645)

19-O-acetylhorhammericine

C23H27N2O5+ (411.1919872)

N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcarbamic acid ethyl ester

C19H33N5O5 (411.24815680000006)

N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcarbamic acid ethyl ester

C19H33N5O5 (411.24815680000006)

N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamic acid ethyl ester

C19H33N5O5 (411.24815680000006)

N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamic acid ethyl ester

C19H33N5O5 (411.24815680000006)

N-tert-butyl-2-(4-tert-butyl-N-(2-methoxy-1-oxoethyl)anilino)-2-(3-pyridinyl)acetamide

C24H33N3O3 (411.2521788)

2-(9-Oxononanoyl)-sn-glycero-3-phosphocholine

C17H34NO8P (411.2021934)

Val-Phe-Phe

C23H29N3O4 (411.21579540000005)

Phe-val-phe

C23H29N3O4 (411.21579540000005)

N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcarbamic acid ethyl ester

C19H33N5O5 (411.24815680000006)

(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-8-phenyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C24H33N3O3 (411.2521788)

2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.21579540000005)

(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-8-phenyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C24H33N3O3 (411.2521788)

(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-8-phenyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C24H33N3O3 (411.2521788)

(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-8-phenyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C24H33N3O3 (411.2521788)

N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamic acid ethyl ester

C19H33N5O5 (411.24815680000006)

N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamic acid ethyl ester

C19H33N5O5 (411.24815680000006)

N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamic acid ethyl ester

C19H33N5O5 (411.24815680000006)

(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-8-phenyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C24H33N3O3 (411.2521788)

(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-8-phenyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C24H33N3O3 (411.2521788)

(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-8-phenyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C24H33N3O3 (411.2521788)

(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-8-phenyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C24H33N3O3 (411.2521788)

(2R,3R,3aS,9bS)-7-(cyclopenten-1-yl)-1-(cyclopropanecarbonyl)-N-ethyl-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C23H29N3O4 (411.21579540000005)

(1S,9R,10R,11R)-N-cyclobutyl-5-(4-fluorophenyl)-10-(hydroxymethyl)-12-methyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C23H26FN3O3 (411.1958098)

(2R,3S)-8-[2-(2-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C23H26FN3O3 (411.1958098)

(2S,3R)-8-[2-(2-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C23H26FN3O3 (411.1958098)

2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.21579540000005)

2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.21579540000005)

2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.21579540000005)

2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.21579540000005)

2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.21579540000005)

2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.21579540000005)

N-[3-(dimethylamino)propyl]-2-[(2R,5R,6S)-5-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

C19H33N5O5 (411.24815680000006)

N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-5-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

C19H33N5O5 (411.24815680000006)

N-[3-(dimethylamino)propyl]-2-[(2S,5R,6R)-5-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

C19H33N5O5 (411.24815680000006)

(2S,3S,3aR,9bR)-7-(1-cyclopentenyl)-1-[cyclopropyl(oxo)methyl]-N-ethyl-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C23H29N3O4 (411.21579540000005)

(1R,9S,10S,11S)-N-cyclobutyl-5-(4-fluorophenyl)-10-(hydroxymethyl)-12-methyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C23H26FN3O3 (411.1958098)

(2R,3R)-N-cyclohexyl-1-(cyclopentylmethyl)-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptane-6-carboxamide

C25H37N3O2 (411.2885622)

(2S,3S)-N-cyclohexyl-1-(cyclopentylmethyl)-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptane-6-carboxamide

C25H37N3O2 (411.2885622)

(6S,7S,8S)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H26FN3O3 (411.1958098)

(6R,7R,8R)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H26FN3O3 (411.1958098)

(6S,7R,8R)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H26FN3O3 (411.1958098)

2-(dimethylamino)-1-[(2S,3R)-6-[(4-fluorophenyl)-oxomethyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone

C23H26FN3O3 (411.1958098)

[(1S)-1-(cyclohexylmethyl)-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol

C25H37N3O2 (411.2885622)

(2S,3R)-8-[2-(2-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C23H26FN3O3 (411.1958098)

(2R,3S)-8-[2-(2-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C23H26FN3O3 (411.1958098)

2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.21579540000005)

2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.21579540000005)

2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.21579540000005)

2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.21579540000005)

2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.21579540000005)

2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.21579540000005)

2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.21579540000005)

2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C23H29N3O4 (411.21579540000005)

2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C23H29N3O4 (411.21579540000005)

N-[3-(dimethylamino)propyl]-2-[(2S,5R,6S)-5-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

C19H33N5O5 (411.24815680000006)

N-[3-(dimethylamino)propyl]-2-[(2S,5S,6R)-5-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

C19H33N5O5 (411.24815680000006)

N-[3-(dimethylamino)propyl]-2-[(2S,5S,6S)-5-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

C19H33N5O5 (411.24815680000006)

N-[3-(dimethylamino)propyl]-2-[(2R,5S,6S)-5-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

C19H33N5O5 (411.24815680000006)

(2R,3R,3aS,9bS)-7-(1-cyclohexenyl)-1-(cyclopropylmethyl)-N-ethyl-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C24H33N3O3 (411.2521788)

(2S,3R)-1-acetyl-N-cyclohexyl-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptane-6-carboxamide

C24H33N3O3 (411.2521788)

(2S,3S)-1-acetyl-N-cyclohexyl-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptane-6-carboxamide

C24H33N3O3 (411.2521788)

1-[(2R,3R)-6-(cyclobutanecarbonyl)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptan-1-yl]-2-(dimethylamino)ethanone

C24H33N3O3 (411.2521788)

1-[(2S,3R)-6-(cyclobutanecarbonyl)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptan-1-yl]-2-(dimethylamino)ethanone

C24H33N3O3 (411.2521788)

1-[(2S,3S)-6-(cyclobutanecarbonyl)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptan-1-yl]-2-(dimethylamino)ethanone

C24H33N3O3 (411.2521788)

(6S,7R,8S)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H26FN3O3 (411.1958098)

(6S,7S,8R)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H26FN3O3 (411.1958098)

(6R,7S,8S)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H26FN3O3 (411.1958098)

(6R,7R,8S)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H26FN3O3 (411.1958098)

Phe-Phe-Val

C23H29N3O4 (411.21579540000005)

Gln-His-Lys

C17H29N7O5 (411.22300640000003)

His-Lys-Lys

C18H33N7O4 (411.2593898)

Lys-Lys-His

C18H33N7O4 (411.2593898)

Lys-Gln-His

C17H29N7O5 (411.22300640000003)

Gln-Lys-His

C17H29N7O5 (411.22300640000003)

His-Gln-Lys

C17H29N7O5 (411.22300640000003)

His-Lys-Gln

C17H29N7O5 (411.22300640000003)

Lys-His-Gln

C17H29N7O5 (411.22300640000003)

alpha-L-Rhap-(1->3)-beta-D-GlcpO[CH2]5NH2

C17H33NO10 (411.2104358)

1-ethyl-2-[5-(1-ethyl-3,3-dimethyl-1,3-dihydro-2H-indol-2-ylidene)penta-1,3-dien-1-yl]-3,3-dimethyl-3H-indolium

C29H35N2+ (411.280009)

N-[(2S)-1-oxo-1-[[(2S)-1-oxo-1-[2-(2,4,5-trihydroxyphenyl)ethylamino]propan-2-yl]amino]propan-2-yl]carbamic acid tert-butyl ester

C19H29N3O7 (411.2005404)

(2-Hydroxy-3-undecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C19H42NO6P (411.27496020000007)

2-Aminoethyl (2-hydroxy-3-tetradecoxypropyl) hydrogen phosphate

C19H42NO6P (411.27496020000007)

Lnape 9:0/N-3:0

C17H34NO8P (411.2021934)

Lnape 6:0/N-6:0

C17H34NO8P (411.2021934)

Lnape 3:0/N-9:0

C17H34NO8P (411.2021934)

Lnape 7:0/N-5:0

C17H34NO8P (411.2021934)

Lnape 5:0/N-7:0

C17H34NO8P (411.2021934)

Lnape 4:0/N-8:0

C17H34NO8P (411.2021934)

Lnape 8:0/N-4:0

C17H34NO8P (411.2021934)

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] tridecanoate

C18H38NO7P (411.23857680000003)

Lnape 2:0/N-10:0

C17H34NO8P (411.2021934)

Lnape 10:0/N-2:0

C17H34NO8P (411.2021934)

(2-Acetyloxy-3-octoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C18H38NO7P (411.23857680000003)

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] pentanoate

C18H38NO7P (411.23857680000003)

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonoxypropan-2-yl] butanoate

C18H38NO7P (411.23857680000003)

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] acetate

C18H38NO7P (411.23857680000003)

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] propanoate

C18H38NO7P (411.23857680000003)

(3-Acetyloxy-2-heptanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C17H34NO8P (411.2021934)

(2-Hexanoyloxy-3-propanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C17H34NO8P (411.2021934)

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] heptanoate

C17H34NO8P (411.2021934)

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] octanoate

C17H34NO8P (411.2021934)

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] nonanoate

C17H34NO8P (411.2021934)

(3-Butanoyloxy-2-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C17H34NO8P (411.2021934)

[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] decanoate

C17H34NO8P (411.2021934)

lysoDGTS 12:3

C22H37NO6 (411.26207420000003)

2-[Hydroxy-[3-hydroxy-2-(pentanoylamino)octoxy]phosphoryl]oxyethyl-trimethylazanium

C18H40N2O6P+ (411.26238500000005)

2-[(2-Acetamido-3-hydroxyundecoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C18H40N2O6P+ (411.26238500000005)

2-[Hydroxy-[3-hydroxy-2-(propanoylamino)decoxy]phosphoryl]oxyethyl-trimethylazanium

C18H40N2O6P+ (411.26238500000005)

2-[[2-(Butanoylamino)-3-hydroxynonoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C18H40N2O6P+ (411.26238500000005)

1-(10-{2-[4-(2-hydroxyethyl)piperazin-1-yl]ethyl}-10H-phenothiazin-2-yl)propan-1-one

C23H29N3O2S (411.19803740000003)

1,2-dihexanoyl-sn-glycero-3-phosphoethanolamine

C17H34NO8P (411.2021934)

1-tridecanoyl-sn-glycero-3-phosphoethanolamine

C18H38NO7P (411.23857680000003)

N-arachidonoyltaurine

C22H37NO4S (411.24431620000007)

A fatty acid-taurine conjugate derived from arachidonic acid.

19-O-acetylhoerhammericine(1+)

C23H27N2O5 (411.1919872)

An ammonium ion derivative resulting from the protonation of the tertiary amino group of 19-O-acetylhoerhammericine. The major species at pH 7.3. Note the stereoconfiguration of the epoxy group is based on CHEBI:144374, and of the 19-acetoxy group on CHEBI:144372.

NA-Cys 20:2(11Z,14Z)

C23H41NO3S (411.28069960000005)

NA-Dopamine 18:4(6Z,9Z,12Z,15Z)

C26H37NO3 (411.27732920000005)

NA-Met 18:2(9E,12E)

C23H41NO3S (411.28069960000005)

NA-Met 18:2(9Z,12Z)

C23H41NO3S (411.28069960000005)

NA-Taurine 20:4(5Z,8Z,11Z,14Z)

C22H37NO4S (411.24431620000007)

CAR DC15:2

C22H37NO6 (411.26207420000003)

MGTS 12:3

C22H37NO6 (411.26207420000003)

LPC 9:1;O

C17H34NO8P (411.2021934)

LPE O-14:0

C19H42NO6P (411.27496020000007)

PE 10:0/2:0

C17H34NO8P (411.2021934)

Lys-His-Lys

C18H33N7O4 (411.2593898)

ST 18:2;O6;Gly

C20H29NO8 (411.1893074)

ST 19:1;O5;Gly

C21H33NO7 (411.22569080000005)

ST 20:0;O4;Gly

C22H37NO6 (411.26207420000003)

ST 22:6;O3;Gly

C24H29NO5 (411.20456240000004)

ST 23:5;O2;Gly

C25H33NO4 (411.2409458000001)

ST 19:2;O2;Tau

C21H33NO5S (411.2079328000001)

MK-6884

C25H25N5O (411.2059)

MK-6884 is a M4 muscarinic receptor positive allosteric modulator (PAM) with a Ki value of 0.19 nM. MK-6884 can be used for the research of the neurodegenerative diseases. MK-6884 can be conveniently radiolabeled with carbon-11 and as a positron emission tomography (PET) imaging agent[1].